102 related articles for article (PubMed ID: 14963350)
61. Increased expression of sialyl-Lewis A correlates with poor survival in upper urinary tract urothelial cancer patients.
Saito K; Fujii Y; Kawakami S; Hayashi T; Arisawa C; Koga F; Kageyama Y; Kihara K
Anticancer Res; 2003; 23(4):3441-6. PubMed ID: 12926087
[TBL] [Abstract][Full Text] [Related]
62. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
Lai IR; Lee WJ; Huang MT; Lin HH
Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
[TBL] [Abstract][Full Text] [Related]
63. Clinical study on recurrence in bladder cancer patients undergoing total cystectomy--statistical analysis of factors related to recurrence.
Honda N; Yamada Y; Mitsui K; Mizumoto H; Taki T; Kamijyo A; Okada M; Hibi H; Fukatsu H
Hinyokika Kiyo; 1999 May; 45(5):317-24. PubMed ID: 10410313
[TBL] [Abstract][Full Text] [Related]
64. Pancreaticoduodenectomy for duodenal papilla carcinoma: A single-centre 9-year retrospective study of 112 patients with long-term follow-up.
Lian PL; Chang Y; Xu XC; Zhao Z; Wang XQ; Xu KS
World J Gastroenterol; 2017 Aug; 23(30):5579-5588. PubMed ID: 28852317
[TBL] [Abstract][Full Text] [Related]
65. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
66. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
[TBL] [Abstract][Full Text] [Related]
67. Prognostic significance of serum γ-glutamyltransferase in patients with advanced urothelial carcinoma.
Takemura K; Fukushima H; Ito M; Kataoka M; Nakanishi Y; Sakamoto K; Suzuki H; Tobisu KI; Koga F
Urol Oncol; 2019 Feb; 37(2):108-115. PubMed ID: 30478012
[TBL] [Abstract][Full Text] [Related]
68. Clinicopathological features of CA19-9-producing gastric cancer.
Yajima H; Omura N; Matai K; Mitsumori N; Yoshida K; Yanaga K
Hepatogastroenterology; 2014; 61(129):221-5. PubMed ID: 24895825
[TBL] [Abstract][Full Text] [Related]
69. [Clinical impact of peripheral lymphocyte counts for metastatic urothelial carcinoma patients treated with chemotherapy].
Sekita N; Nishikawa R; Fujimura M; Takeuchi N; Ogino H; Shibata N; Omura S; Mikami K
Hinyokika Kiyo; 2014 May; 60(5):215-9. PubMed ID: 24894856
[TBL] [Abstract][Full Text] [Related]
70. The evaluation of monocyte lymphocyte ratio as a preoperative predictor in urothelial malignancies: a pooled analysis based on comparative studies.
Zhu X; Wu SQ; Xu R; Wang YH; Zhong ZH; Zhang L; Zhao XK
Sci Rep; 2019 Apr; 9(1):6280. PubMed ID: 31000754
[TBL] [Abstract][Full Text] [Related]
71. Significance of CA19-9 in predicting the prognosis of urothelial carcinoma: a hospital based study from Nepal.
Jha DK; Mittal A; Gupta SP; Sathian B
Asian Pac J Cancer Prev; 2013; 14(7):4067-9. PubMed ID: 23991954
[TBL] [Abstract][Full Text] [Related]
72. ABO and rhesus blood groups as prognostic factors in transitional cell carcinomas of the upper urinary tract.
Krogh J; Kvist E
Urol Int; 1992; 48(1):9-13. PubMed ID: 1598741
[TBL] [Abstract][Full Text] [Related]
73. CA19-9 as a predictor of recurrence in patients with colorectal cancer.
Nakayama T; Watanabe M; Teramoto T; Kitajima M
J Surg Oncol; 1997 Dec; 66(4):238-43. PubMed ID: 9425326
[TBL] [Abstract][Full Text] [Related]
74. Ca 125 as a marker of tumor activity in advanced urothelial malignancy.
Izes JK; Dyer MW; Callum MG; Bankes P; Libertino JA; Caffrey JA
J Urol; 2001 Jun; 165(6 Pt 1):1908-13. PubMed ID: 11371879
[TBL] [Abstract][Full Text] [Related]
75. Prognostic significance of the immunohistochemical localization and serological detection of CA19-9 tumor antigen in colon carcinoma.
Plemenos MF; Dimas C; Kotsios A; Gennatas K; Pafiti AK
J BUON; 2004; 9(1):73-6. PubMed ID: 17385832
[TBL] [Abstract][Full Text] [Related]
76. The impact of perioperative CA19-9 change on the survival and recurrence patterns after adjuvant chemoradiotherapy in resectable extrahepatic cholangiocarcinoma.
Kim BH; Kim E; Kim K; Jang JY; Kim SW; Oh DY; Chie EK
J Surg Oncol; 2018 Mar; 117(3):380-388. PubMed ID: 28940411
[TBL] [Abstract][Full Text] [Related]
77. [Serum concentration of laminin in transitional cell carcinoma].
Iwata S; Isobe H; Fujime M; Kitagawa R; Horikoshi S; Funabiki K; Koide H
Nihon Hinyokika Gakkai Zasshi; 1990 Apr; 81(4):518-23. PubMed ID: 2374323
[TBL] [Abstract][Full Text] [Related]
78. Cutaneous metastasis of micropapillary urothelial carcinoma.
Truong H; Parsons TM; Trabulsi EJ
Urology; 2015 Feb; 85(2):e7-8. PubMed ID: 25559725
[TBL] [Abstract][Full Text] [Related]
79. [Urothelium cancer with trophoblastic differentiation. An unusual case of a 77 year old patient].
Krah X; Klose E; Atanassov G; Eschholz G; Kosmehl H; Weber HM
Urologe A; 2006 Jan; 45(1):81-4. PubMed ID: 16328216
[TBL] [Abstract][Full Text] [Related]
80. Marked elevation of CA19-9 in a patient with idiopathic pulmonary fibrosis: CA19-9 as a bad prognostic factor.
Fujita J; Obayashi Y; Yamadori I; Ohtsuki Y; Miyawaki H; Hojo S; Furukawa Y; Takahara J
Respirology; 1998 Sep; 3(3):211-4. PubMed ID: 9767623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
